Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
Clinical profile of malay children with optic neuritis.
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.
Teva to present positive data for glatiramer acetate 40 mg/1 ml given three times weekly for relapsing-remitting MS
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
2nd Annual Congress on Neurology and Epidemiology
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Physiopathological Roles of p2x Receptors in the Central Nervous System.
Amiloride HCl
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.
Pregnancy outcomes in female patients and partners of male patients in the teriflunomide clinical development program.
Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects.
Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.
Centocor briefing document for Ustekinumab, submitted to FDA

Pages